Luan SY - Search Results

1

The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta-Analysis.

Xiao X, Hong HG, Zeng X, Yang YS, Luan SY, Li Y, Chen LQ, Yuan Y. Xiao X, et al. Among authors: luan sy. World J Surg. 2020 Dec;44(12):4161-4174. doi: 10.1007/s00268-020-05721-w. Epub 2020 Aug 5. World J Surg. 2020. PMID: 32761259 Review.

2

Coniform Gastric Tube for End-to-End Anastomosis During Minimally Invasive McKeown Esophagectomy.

Zheng X, Yang YS, Hu WP, Xiao X, Luan SY, Chen LQ, Yuan Y. Zheng X, et al. Among authors: luan sy. Ann Thorac Surg. 2020 Apr;109(4):e297-e300. doi: 10.1016/j.athoracsur.2019.10.032. Epub 2019 Nov 30. Ann Thorac Surg. 2020. PMID: 31794736

3

The emerging role of long noncoding RNAs in esophageal carcinoma: from underlying mechanisms to clinical implications.

Luan S, Yang Y, Zhou Y, Zeng X, Xiao X, Liu B, Yuan Y. Luan S, et al. Cell Mol Life Sci. 2021 Apr;78(7):3403-3422. doi: 10.1007/s00018-020-03751-0. Epub 2021 Jan 19. Cell Mol Life Sci. 2021. PMID: 33464385 Free PMC article. Review.

4

Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer.

Mao C, Zeng X, Zhang C, Yang Y, Xiao X, Luan S, Zhang Y, Yuan Y. Mao C, et al. Front Cell Dev Biol. 2021 Feb 11;9:612451. doi: 10.3389/fcell.2021.612451. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33644048 Free PMC article. Review.

5

Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment.

Luan S, Zeng X, Zhang C, Qiu J, Yang Y, Mao C, Xiao X, Zhou J, Zhang Y, Yuan Y. Luan S, et al. Front Cell Dev Biol. 2021 Mar 19;9:664816. doi: 10.3389/fcell.2021.664816. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33816512 Free PMC article. Review.

6

Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications.

Zhou J, Sun S, Luan S, Xiao X, Yang Y, Mao C, Chen L, Zeng X, Zhang Y, Yuan Y. Zhou J, et al. Front Oncol. 2021 Oct 18;11:717242. doi: 10.3389/fonc.2021.717242. eCollection 2021. Front Oncol. 2021. PMID: 34733778 Free PMC article. Review.

7

The development and progress of nanomedicine for esophageal cancer diagnosis and treatment.

Li X, Chen L, Luan S, Zhou J, Xiao X, Yang Y, Mao C, Fang P, Chen L, Zeng X, Gao H, Yuan Y. Li X, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):873-885. doi: 10.1016/j.semcancer.2022.01.007. Epub 2022 Jan 21. Semin Cancer Biol. 2022. PMID: 35074509 Review.

8

Acid-Responsive Aggregated Gold Nanoparticles for Radiosensitization and Synergistic Chemoradiotherapy in the Treatment of Esophageal Cancer.

Luan S, Xie R, Yang Y, Xiao X, Zhou J, Li X, Fang P, Zeng X, Yu X, Chen M, Gao H, Yuan Y. Luan S, et al. Small. 2022 May;18(19):e2200115. doi: 10.1002/smll.202200115. Epub 2022 Mar 9. Small. 2022. PMID: 35261151

9

Prognostic Value of Geriatric Nutritional Risk Index in Esophageal Carcinoma: A Systematic Review and Meta-Analysis.

Zhou J, Fang P, Li X, Luan S, Xiao X, Gu Y, Shang Q, Zhang H, Yang Y, Zeng X, Yuan Y. Zhou J, et al. Front Nutr. 2022 Mar 25;9:831283. doi: 10.3389/fnut.2022.831283. eCollection 2022. Front Nutr. 2022. PMID: 35399659 Free PMC article.

10

Overexpressed COL3A1 has prognostic value in human esophageal squamous cell carcinoma and promotes the aggressiveness of esophageal squamous cell carcinoma by activating the NF-κB pathway.

Zhou J, Yang Y, Zhang H, Luan S, Xiao X, Li X, Fang P, Shang Q, Chen L, Zeng X, Yuan Y. Zhou J, et al. Biochem Biophys Res Commun. 2022 Jul 12;613:193-200. doi: 10.1016/j.bbrc.2022.05.029. Epub 2022 May 13. Biochem Biophys Res Commun. 2022. PMID: 35598375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters